Chen Diane, Strang John F, Kolbuck Victoria D, Rosenthal Stephen M, Wallen Kim, Waber Deborah P, Steinberg Laurence, Sisk Cheryl L, Ross Judith, Paus Tomas, Mueller Sven C, McCarthy Margaret M, Micevych Paul E, Martin Carol L, Kreukels Baudewijntje P C, Kenworthy Lauren, Herting Megan M, Herlitz Agneta, Haraldsen Ira R J Hebold, Dahl Ronald, Crone Eveline A, Chelune Gordon J, Burke Sarah M, Berenbaum Sheri A, Beltz Adriene M, Bakker Julie, Eliot Lise, Vilain Eric, Wallace Gregory L, Nelson Eric E, Garofalo Robert
Potocsnak Family Division of Adolescent and Young Adult Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Pritzker Department of Psychiatry and Behavioral Health, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Transgend Health. 2020 Dec 11;5(4):246-257. doi: 10.1089/trgh.2020.0006. eCollection 2020.
Pubertal suppression is standard of care for early pubertal transgender youth to prevent the development of undesired and distressing secondary sex characteristics incongruent with gender identity. Preliminary evidence suggests pubertal suppression improves mental health functioning. Given the widespread changes in brain and cognition that occur during puberty, a critical question is whether this treatment impacts neurodevelopment. A Delphi consensus procedure engaged 24 international experts in neurodevelopment, gender development, puberty/adolescence, neuroendocrinology, and statistics/psychometrics to identify priority research methodologies to address the empirical question: is pubertal suppression treatment associated with real-world neurocognitive sequelae? Recommended study approaches reaching 80% consensus were included in the consensus parameter. The Delphi procedure identified 160 initial expert recommendations, 44 of which ultimately achieved consensus. Consensus study design elements include the following: a minimum of three measurement time points, pubertal staging at baseline, statistical modeling of sex in analyses, use of analytic approaches that account for heterogeneity, and use of multiple comparison groups to minimize the limitations of any one group. Consensus study comparison groups include untreated transgender youth matched on pubertal stage, cisgender (i.e., gender congruent) youth matched on pubertal stage, and an independent sample from a large-scale youth development database. The consensus domains for assessment includes: mental health, executive function/cognitive control, and social awareness/functioning. An international interdisciplinary team of experts achieved consensus around primary methods and domains for assessing neurodevelopmental effects (i.e., benefits and/or difficulties) of pubertal suppression treatment in transgender youth.
青春期抑制是早期青春期跨性别青少年的标准治疗方法,以防止出现与性别认同不一致的不良和令人苦恼的第二性征。初步证据表明,青春期抑制可改善心理健康状况。鉴于青春期会发生广泛的大脑和认知变化,一个关键问题是这种治疗是否会影响神经发育。一项德尔菲共识程序邀请了24位国际专家,他们分别来自神经发育、性别发育、青春期/青少年期、神经内分泌学以及统计学/心理测量学领域,以确定优先研究方法,来解决这个实证问题:青春期抑制治疗是否与现实世界中的神经认知后遗症有关?达到80%共识的推荐研究方法被纳入共识参数。德尔菲程序确定了160条初步专家建议,其中44条最终达成了共识。共识研究设计要素包括以下几点:至少三个测量时间点、基线时的青春期分期、分析中的性别统计建模、使用考虑异质性的分析方法以及使用多个比较组以尽量减少任何一组的局限性。共识研究比较组包括在青春期阶段匹配的未接受治疗的跨性别青少年、在青春期阶段匹配的顺性别(即性别一致)青少年,以及来自大规模青少年发展数据库的独立样本。评估的共识领域包括:心理健康、执行功能/认知控制和社会意识/功能。一个国际跨学科专家团队就评估跨性别青少年青春期抑制治疗的神经发育影响(即益处和/或困难)的主要方法和领域达成了共识。